| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Heller Bridgette P serves as a Director at ARMK and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $4.6M at current prices.
Historically, Heller Bridgette P's trades have earned a middling insider score of 62/100 across 7 rated trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +14.7%.
The biggest single holding is DXCM (~$2.6M) as Director. The recent filings there lean toward selling, a net 6,351 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | DXCM Dexcom Inc | Director | Sell | 1,012 | $68.01 | $68,826.12 | -3.7% | -10.0% | - | |
| Nov 12, 2025 | DXCM Dexcom Inc | Director | Sell | 1,012 | $58.07 | $58,766.84 | -3.6% | +14.3% | - | |
| Mar 17, 2025 | DXCM Dexcom Inc | Director | Sell | 352 | $70.33 | $24,756.16 | -1.5% | +16.3% | -5.6% | |
| Dec 16, 2024 | DXCM Dexcom Inc | Director | Sell | 1,000 | $76.87 | $76,870.00 | -4.1% | -6.6% | -13.1% | |
| Sep 16, 2024 | DXCM Dexcom Inc | Director | Sell | 1,000 | $70.00 | $70,000.00 | -3.9% | +9.0% | +9.2% | |
| Jun 14, 2024 | DXCM Dexcom Inc | Director | Sell | 1,000 | $113.55 | $113,550.00 | -3.8% | -40.6% | -29.3% | |
| Sep 12, 2023 | DXCM Dexcom Inc | Director | Sell | 600 | $106.56 | $63,936.00 | -2.5% | +12.4% | -34.7% | |
| Dec 15, 2020 | DXCM Dexcom Inc | Director | Sell | 375 | $356.65 | $133,743.75 | -9.8% | - | - |